Gene · 4325
Papers1,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,529
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
| Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci. | medRxiv | 2025 | 41445605 | PubTator, text mining | PubMed |
| Multi-omics Mendelian randomization and single-cell analysis identify novel therapeutic targets for osteosarcopenia. | J Gerontol A Biol Sci Med Sci | 2025 | 41071635 | PubTator, text mining | PubMed |
| MicroRNAs and Cancer Racial Disparities. | Wiley Interdiscip Rev RNA | 2025 | 40998459 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases as Candidate Antigenic Determinants for Anti-Tumor Autoantibodies in Human Ovarian Cancer: A Post Hoc Analysis. | FASEB J | 2025 | 40985572 | PubTator, text mining | PubMed |
| Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation. | Redox Biol | 2025 | 40972157 | PubTator, text mining | PubMed |
| Synovial Fluid Proteomic Signatures in Different Subtypes of Juvenile Idiopathic Arthritis. | Scand J Immunol | 2025 | 40855397 | PubTator, text mining | PubMed |
| Deciphering the molecular clock: exploring molecular mechanisms and genetic influences on skin ageing. | Biogerontology | 2025 | 40751759 | PubTator, text mining | PubMed |
| Retraction: MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition. | Ann Transl Med | 2025 | 40689073 | PubTator, text mining | PubMed |
| Mechanisms of matrix metalloproteinase 16 in development and cancer. | Gene | 2025 | 40675518 | PubTator, text mining | PubMed |
| RNA G-quadruplex structure targeting and imaging: recent advances and future directions. | RNA | 2025 | 40473419 | PubTator, text mining | PubMed |
| The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition. | J Cell Mol Med | 2025 | 39900560 | PubTator, text mining | PubMed |
| Causal relationship between matrix metalloproteinase and pulmonary embolism: a bidirectional two-sample Mendelian randomization study. | Sci Rep | 2025 | 39747197 | PubTator, text mining | PubMed |
| Construction and Bioinformatics Analysis of ceRNA Regulatory Networks in Idiopathic Pulmonary Fibrosis. | Biochem Genet | 2025 | 38871957 | PubTator, text mining | PubMed |
| Causal association between matrix metalloproteinases and diabetic neuropathy: a two-sample Mendelian randomization study. | Front Endocrinol (Lausanne) | 2024 | 39877847 | PubTator, text mining | PubMed |
| Capecitabine regulates proliferation and apoptosis of ovarian cancer SKOV3 cells via the miR-29b-3p/MMP16 molecular axis. | Am J Transl Res | 2024 | 39678594 | PubTator, text mining | PubMed |
| Prediction of Human Papillomavirus-Host Oncoprotein Interactions Using Deep Learning. | Bioinform Biol Insights | 2024 | 39664297 | PubTator, text mining | PubMed |
| Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma. | Front Oncol | 2024 | 39493455 | PubTator, text mining | PubMed |
| Reducing metastasis ability of gastric cancer cell line by targeting MMP16 using miR-193a-5p and 5-FU. | Adv Med Sci | 2024 | 39341599 | PubTator, text mining | PubMed |
| Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways. | Front Oncol | 2024 | 39267845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4325/papers?page=2